For the Inventor, By the Inventor

Enter assignee name

San Ramon, CA, United States of America

Odyssey Thera Inc.

USPTO Granted Patents = 16

EPO Patents = 5

Forward Citations = 103

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Stephen William Watson Michnick (15 out of 18 patents)

Ingrid Remy (7 out of 10 patents)

Marnie L MacDonald (6 out of 6 patents)

4. Jane Lamerdin (5 out of 5 patents)

5. John K Westwick (4 out of 5 patents)

6. Joelle Nina Pelletier (4 out of 6 patents)

7. Helen Yu (2 out of 7 patents)

8. Andreas Plückthun (2 out of 19 patents)

9. Joelle Nina Polletier (2 out of 2 patents)

10. Katja M Arndt (2 out of 2 patents)

11. André Galarneau (1 out of 1 patent)

12. Brigitte Keon (1 out of 1 patent)

13. Normand Brisson (1 out of 3 patents)

14. André Galarneau (1 out of 1 patent)

15. Marnie Macdonald (0 patent)

16 patents: Sort by Forward Citations

1. 8192944 - Protein fragment complementation assays for the detection of biological or drug interactions (2012-06-05),

2. 8101364 - Fragments of fluorescent proteins for protein fragment complementation assays (2012-01-24),

3. 7989218 - Protein fragment complementation assays for the detection of biological or drug interactions (2011-08-02),

4. 7955832 - [object Object] (2011-06-07),

5. 7935493 - Protein fragment complementation assays for high-throughput and high-content screening (2011-05-03),

6. 7855167 - In vivo screening of protein-protein interactions with protein-fragment complementation assays (2010-12-21),

7. 7625700 - [object Object] (2009-12-01),

8. 7488583 - Fragment complementation assays for G-protein-coupled receptors and their signaling pathways (2009-02-10),

9. 7306914 - Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy (2007-12-11),

10. 7166424 - Fragments of fluorescent proteins for protein fragment complementation assays (2007-01-23),

11. 7160691 - Protein fragment complementation assays for the detection of biological or drug interactions (2007-01-09),

12. 7062219 - Protein fragment complementation assays for high-throughput and high-content screening (2006-06-13),

13. 6929916 - Protein fragment complementation assays for the detection of biological or drug interactions (2005-08-16),

14. 6897017 - Vivo library-versus-library selection of optimized protein-protein interactions (2005-05-24),

15. 6872871 - Mapping molecular interactions in plants with protein fragments complementation assays (2005-03-29),

Odyssey Thera Inc. is a leading biotechnology company focused on advancing drug discovery and development through innovative cellular signaling analysis tools. The company utilizes proprietary high-throughput screening technology to rapidly evaluate and optimize drug candidates for a wide range of therapeutic areas. Odyssey Thera's expertise lies in identifying novel drug targets, mode of action analysis, and personalized medicine solutions. With a strong commitment to scientific excellence and collaboration, Odyssey Thera is driving advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#18 in San Ramon, CA

#4,620 in California

#19,271 in US

#36,634 in the World

San Ramon, CA, United States of America

Odyssey Thera Inc.

Forward Citations = 103

17 inventors:

Stephen William Watson Michnick (15 out of 18 patents)

Ingrid Remy (7 out of 10 patents)

Marnie L MacDonald (6 out of 6 patents)

4. Jane Lamerdin (5 out of 5 patents)

5. John K Westwick (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…